AFC-HD AMS Life Science Co.,Ltd.
2927株式会社AFC-HDアムスライフサイエンス
Latest half-year results
First half · fiscal year to 2026-08 · filed 2026-04-14For the first half of the fiscal year to 2026-08: Revenue ¥16.8 billion (+1.4% YoY), Ordinary income ¥1.2 billion (-10.4% YoY), Net income ¥0.8 billion (-9.1% YoY).
| This period | Year on year | |
|---|---|---|
| Revenue | ¥16.8bn | +1.4% |
| Ordinary profit | ¥1.2bn | -10.4% |
| Net profit to owners | ¥801m | -9.1% |
From the securities report on EDINET, which states no forecast. History via /v1/companies/2927/earnings-releases.
Financials
Japan GAAP · consolidated · fiscal year to 2025-08-31- Revenue
- ¥32.7bn
- Net income
- ¥1.4bn
- ROE
- 10.0%
- Equity ratio
- 30.9%
- Dividend / share
- ¥34
- Employees
- 1,008
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2025-08-31 | ¥32.7bn | ¥1.4bn | ¥48.7bn | ¥15.2bn | 10.0% | ¥102.98 | ¥1.8bn |
| 2024-08-31 | ¥30.2bn | ¥1.3bn | ¥47.0bn | ¥14.0bn | 9.3% | ¥89.2 | ¥1.5bn |
| 2023-08-31 | ¥25.6bn | ¥1.1bn | ¥41.1bn | ¥13.2bn | 8.6% | ¥78.51 | ¥0.9bn |
| 2022-08-31 | ¥23.0bn | ¥0.7bn | ¥37.3bn | ¥12.4bn | 6.1% | ¥52.33 | ¥1.5bn |
| 2021-08-31 | ¥22.4bn | ¥1.5bn | ¥35.8bn | ¥12.7bn | 13.4% | ¥107.12 | ¥2.6bn |
Indicators
Computed by us from filings · fiscal year to 2025-08-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | 10 | 58.4 |
| Ordinary margin | 0.0748 | 53.8 |
| Equity ratio, % | 30.9 | 15 |
| Revenue growth | 0.0818 | 63.7 |
| Net income growth | 0.1569 | 52.2 |
| Operating cash flow / assets | 0.0367 | 31.9 |
Results wording balance: +1.00. Proprietary text method; it describes the wording only and does not interpret context.
Interest example: if all ¥23.9bn of reported debt repriced by 50 basis points, a year's interest would rise by ¥120m, 6.7% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.
Via /v1/companies/2927/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/2927/segments/v1/companies/2927/votingCross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- 1 issues
- Book value
- ¥59m
- Sold in the year
- — — issues
- Bought in the year
- — — issues
- Mutual, both reports
- 0
- Held by listed cos.
- 0
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| Shizuoka Financial Group, Inc. 5831 | ¥59m | 0.0% | stated |
Purposes, all holdings and mutual flags via /v1/companies/2927/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2025-08-31| Shareholder | Shares | Ratio |
|---|---|---|
| individual holder | 2,087,570 | 14.81% |
| individual holder | 1,181,930 | 8.39% |
| アムスライフサイエンス取引先持株会 | 424,700 | 3.01% |
| individual holder | 403,400 | 2.86% |
| individual holder | 310,000 | 2.20% |
| individual holder | 300,000 | 2.13% |
| individual holder | 129,167 | 0.92% |
| 株式会社静岡銀行 | 124,900 | 0.89% |
| individual holder | 123,100 | 0.87% |
| individual holder | 95,420 | 0.68% |
U.S. funds holding 2927
SEC Form N-PORT, reports to 2026-07-3112 U.S. funds held 89,000 shares worth $0.5m.
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| INTERNATIONAL CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 25,271 | $0.1m | 0.000% | 2026-07-31 |
| Avantis International Small Cap Value ETF American Century ETF Trust | 15,500 | $0.1m | 0.000% | 2026-05-31 |
| International Vector Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 10,400 | $0.1m | 0.001% | 2026-07-31 |
| Dimensional International Core Equity 2 ETF Dimensional ETF Trust | 10,200 | $0.1m | 0.000% | 2026-07-31 |
| Dimensional International Small Cap ETF Dimensional ETF Trust | 8,200 | $0.0m | 0.001% | 2026-07-31 |
Up to 25 funds per stock via the API.
Get this as JSON
GET /v1/companies/2927
GET /v1/companies/2927/financials
GET /v1/companies/2927/details
GET /v1/companies/2927/segments
GET /v1/companies/2927/voting
GET /v1/companies/2927/tender-offers
GET /v1/companies/2927/indicators
GET /v1/companies/2927/earnings-releases
GET /v1/events?ticker=2927
GET /v1/companies/2927/trades
GET /v1/companies/2927/cross-holdings
GET /v1/companies/2927/brief